For individuals battling Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a debilitating condition, the emergence of this treatment and the formulated version represents a true advancement . These groundbreaking therapies stabilize the transthyretin protein, slowing its destructive build-up and lessening the impact of the disease . Individuals ar… Read More